Navigation Links
Disease and Therapy Review: Bladder Cancer Now Available at ReportsandReports
Date:6/29/2010

DALLAS, June 29, 2010 /PRNewswire/ -- ReportsandReports announces it will carry the Disease and Therapy Review: Bladder Cancer Market Research Report in its Store

Browse the complete Report on: http://www.reportsandreports.com/market-reports/disease-and-therapy-review-bl adder-cancer/

The Bladder Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the cancer market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

    Table of Contents

    I.OVERVIEW

    General description of the condition

    II.INCIDENCE AND PREVALENCE

    - Incidence Table (Canada, US, Mexico, France, Germany, Greece,
      Italy, Russian Federation, Spain, Sweden, UK, China, India, Japan,
      Europe, Worldwide)
    - Prevalence Table (Canada, US, Mexico, France, Germany, Italy,
      Spain, UK, China, India, Japan, Worldwide)
    - Mortality Table (Canada, US, Mexico, France, Germany, Greece,
      Italy, Russian Federation, Spain, Sweden, UK, China, India, Japan,
      Europe, Worldwide)

    III.DIAGNOSIS

    - Symptoms and signs
    - Laboratory findings
    - Imaging
    - Cystouresthroscopy and biopsy
    - Cellular classification

    IV. TREATMENT

    - Surgical therapy
    - Radiotherapy
    - Chemotherapy
    - Interstitial implantation of radioisotopes
    - Clinical trials
    - Outcomes by stage


    V.DOSING AND TREATMENT COSTS
    VI.MARKET SIZE
    VII.COMMENTS
    VIII.REFERENCES/RESOURCES
    Browse all HealthCare Reports at
http://www.reportsandreports.com/market-research/healthcare/
    Browse all Timely Data resources Reports at
http://www.reportsandreports.com/Publishers/timely-data-resources/

Related Reports

Disease and Therapy Review: Colorectal Cancer ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-co lorectal-cancer/)

Disease and Therapy Review: Cervical Cancer ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-ce rvical-cancer/)

Disease and Therapy Review: Prostate Cancer ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-pr ostate-cancer/)

Cancer Bladder Cancer Therapy Area Pipeline Report ( http://www.reportsandreports.com/market-reports/cancer-bladder-cancer-therapy -area-pipeline-report/)

Disease and Therapy Review: Chronic Obstructive Pulmonary Disease (COPD) (http://www.reportsandreports.com/market-reports/disease-and-therapy-review-c hronic-obstructive-pulmonary-disease/)

Disease and Therapy Review: Gastroesophageal Reflux Disease (GERD) (http://www.reportsandreports.com/market-reports/disease-and-therapy-review-g astroesophageal-reflux-disease-ger/)

Disease and Therapy Review: Asthma( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-as thma/)

Disease and Therapy Review: Impetigo( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-im petigo/)

Disease and Therapy Review: Onychomycosis ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-on ychomycosis/)

Disease and Therapy Review: Ulcerative Colitis ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-ul cerative-colitis/)

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

(Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)

    Contact:

    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    http://www.reportsandreports.com/
    http://reportsnreports.wordpress.com/
    http://reportsandreports.blogspot.com/



'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
2. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
3. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
4. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
5. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
6. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
7. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
8. Juvaris BioTherapeutics Announces Six Scientific Presentations at Infectious Diseases Society of America (IDSA) Meeting October 6, 2007
9. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
10. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
11. AAAAI: Call for Entries: Have You Written a Story on Allergic Disease? Win $1000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... FRANCISCO , Feb. 23, 2017   ViaCyte, ... Type 1, a not-for-profit advocacy and education group for ... grant from Beyond Type 1 to support ViaCyte,s efforts ... other insulin-requiring diabetes.  For more than ... cell replacement therapies with a focus on the treatment ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
(Date:2/22/2017)... ... 2017 , ... ProMIS Neurosciences (“ProMIS” or the “Company”), a ... announced it has issued a scientific white paper entitled “Results from recent Alzheimer’s ... commentaries from ProMIS’s scientific team offering insight into the Company’s product portfolio and ...
(Date:2/22/2017)... 22, 2017 Origin (Origin Agritech, LLC, a subsidiary of ... provider, and Arcadia (Arcadia Biosciences, Inc., NASDAQ: ... commercializes agricultural productivity traits and nutritional products, today announced their collaboration ... developed in China to the ... ...
Breaking Biology Technology:
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
Breaking Biology News(10 mins):